ARCHIVES

In Brief: FDA Opens Advisory Committee Consideration Of NDAs, Finds Discussion Is Not Inhibited

This article is from The Cancer Letter archive.

Vol. 02 No. 37 | September 10, 1976

Download PDF Visit The Full Archive

Related Articles

Clinton Budget For NIH “Disappointing,” AACR executive Director Says

May 7, 1993

In Brief: Columiba Adds Presbyterian to Center’s Name: Clinton’s Mother Honored; DeVita move Rumored

March 5, 1993

FDA: If Carboplatin Dose Is Based On Actual GFR Measurements, Package Insert Dosing Instructions Accurate

October 8, 2010

NCCS Networker Volume 10 Issue 3, Winter 1996

January 13, 1996

Pesticides Not A Risk Factor For Long Island Breast Cancer, Study Finds

September 6, 2002

Referral Pattern Change Needed For Quality Care, AACR/ASCO Told

May 16, 1975